Genprex, Inc.
GNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.01 | 0.01 | 0.01 |
| FCF Yield | -49.48% | -61.42% | -111.18% | -41.84% |
| EV / EBITDA | 0.00 | -1.06 | -0.07 | -1.76 |
| Quality | ||||
| ROIC | 0.00% | -336.53% | -102.62% | -267.61% |
| Gross Margin | 0.00% | 0.00% | 0.00% | -4.67% |
| Cash Conversion Ratio | 0.84 | 0.83 | 1.05 | 0.89 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 17.52% | 7.14% | -7.55% | -78.40% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.29 | 0.87 | 0.37 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -19,501.12 |